Our results are in accordance with other authors [16–19] that have reported changes in frequency of CD4+CD25+ T cells and CD4+CD25+FOXP3+ regulatory T cells in atopic diseases, such as asthma, rhinitis, and atopic dermatitis [16–19]. The gene discussed is CD4; the disease is atopic eczema.